Indications
Therapeutic Asset Ratings
91,564
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Cyclophosphamide
Nodular Lymphocyte Predominant Hodgkin Lymphoma
National Cancer Institute (NCI)
P3
BB
(71)
Cyclophosphamide
Gastroesophageal Junction Adenocarcinoma
Beijing Biotech
P3
BB
(71)
Cyclophosphamide
T-Cell Childhood Acute Lymphocytic Leukemia
National Cancer Institute (NCI)
P3
BB
(71)
Cyclophosphamide
Urothelial Carcinoma
Beijing Biotech
P3
BB
(71)
Cyclosporin A
Chronic Myeloid Leukemia
Fred Hutchinson Cancer Center
P3
BB
(71)
Cyclosporin A
Graft Versus Host Disease
Memorial Sloan Kettering Cancer Center
P3
BB
(71)
Docetaxel
Breast Carcinoma
Dana-Farber Cancer Institute
P3
BB
(71)
Etoposide
High Grade B-Cell Lymphoma
University of Washington
P3
BB
(71)
Etoposide
Follicular Lymphoma
David Bond, MD
P3
BB
(71)
Fenofibrate
Primary Biliary Cholangitis
Xijing Hospital of Digestive Diseases
P3
BB
(71)
Fludarabine
Acute Myeloid Leukemia With T(8;21)(Q22;Q22) Translocation
Rutgers, The State University of New Jersey
P3
BB
(71)
Fludarabine
Juvenile Myelomonocytic Leukemia
Children's Oncology Group
P3
BB
(71)
Fludarabine
Myelodysplastic Syndrome With Single Lineage Dysplasia
Fred Hutchinson Cancer Center
P3
BB
(71)
Fludarabine
Myelodysplastic Syndrome With Excess Blasts
Fred Hutchinson Cancer Center
P3
BB
(71)
Idarubicin
Acute Myeloid Leukemia By FAB Classification
University of Nebraska
P3
BB
(71)
Ipilimumab
Metastatic Neoplasm
7 Hills Pharma, LLC
P3
BB
(71)
Irinotecan
Malignant Pancreatic Neoplasm
Jonsson Comprehensive Cancer Center
P3
BB
(71)
Irinotecan
Pancreatic Adenocarcinoma
Jonsson Comprehensive Cancer Center
P3
BB
(71)
Irinotecan
Rectal Carcinoma
SCRI Development Innovations, LLC
P3
BB
(71)
Isocyclophosphamide
High Grade B-Cell Lymphoma
University of California, Davis
P3
BB
(71)
Methotrexate
Hodgkins Lymphoma
Therapeutic Advances in Childhood Leukemia Consortium
P3
BB
(71)
Nivestim
Cutaneous Melanoma
Vastra Gotaland Region
P3
BB
(71)
Obinutuzumab
B-Cell Chronic Lymphocytic Leukemia
Paolo Caimi, MD
P3
BB
(71)
Saroglitazar
Primary Biliary Cholangitis
Zydus Therapeutics Inc.
P3
BB
(71)
Setmelanotide
Obesity Due To Pro-Opiomelanocortin Deficiency
Rhythm Pharmaceuticals, Inc.
P3
BB
(71)
Showing 1126 to 1150 of 42,327 assets
Previous
Page 46 of 1694
Next